Cytisine - A tobacco treatment hiding in plain sight

New England Journal of Medicine

Volumn 371, Issue 25, 2014, Pages 2429-2430

  Rigotti, Nancy A ^a,b  

^a Division of General Medicine   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTISINE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; PLACEBO; VARENICLINE; ALKALOID; AZOCINE DERIVATIVE; QUINOLIZINE DERIVATIVE;

COMBINATION CHEMOTHERAPY; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; EUROPE; FOLLOW UP; HEALTH CARE COST; HELP SEEKING BEHAVIOR; HUMAN; LOWEST INCOME GROUP; NAUSEA AND VOMITING; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; SMOKING; SMOKING CESSATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ANTAGONISTS AND INHIBITORS; FEMALE; MALE; PROCEDURES; TOBACCO USE DISORDER;

ALKALOIDS; AZOCINES; FEMALE; HUMANS; MALE; NICOTINE; QUINOLIZINES; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84919359597     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1412313     Document Type: Editorial

References (11)

1. Walker N, Howe C, Glover M, et al. Cytisine versus nicotine for smoking cessation. N Engl J Med 2014;371:2353-62.
2. Etter JF. Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med 2006;166:1553-9.
3. Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax 2013;68:1037-42.
4. West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med 2011;365: 1193-200.
5. Vinnikov D, Brimkulov N, Burjebaeva A. A double-blind, randomised, placebo-controlled trial of cytisine for smoking cessation in medium-dependent workers. J Smoking Cessation 2008;3:57-62.
6. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103.
7. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmaticexplanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-75.
8. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;5:CD009329.
9. Prochaska JJ, Das S, Benowitz NL. Cytisine, the world's oldest smoking cessation aid. BMJ 2013;347:f5198.
10. Aveyard P, West R. Cytisine and the failure to market and regulate for human health. Thorax 2013;68:989.
11. Piné-Abata H, McNeill A, Murray R, Bitton A, Rigotti N, Raw M. A survey of tobacco dependence treatment services in 121 countries. Addiction 2013;108:1476-84.